Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.38 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | GMNN | O75496 | 3/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.38 |
| ▸ | BLM | P54132 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | MME | P08473 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 1/20 | 0.37 |
| ▸ | CPA1 | P15085 | 1/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3043003 | 0.88 | LMNA (0.41) | CYP1A2MAPK1LMNAGMNNMAPT | |
| SCHEMBL2354265 | 0.83 | GPR84 (0.42) | CYP1A2MAPK1LMNAGMNNMAPT | |
| SCHEMBL14269783 | 0.82 | ALDH1A1 (0.44) | LMNATSHR | |
| SCHEMBL18348559 | 0.82 | LMNA (0.37) | CYP1A2MAPK1LMNAGMNNMAPT | |
| Ether SCHEMBL6495162 | 0.80 | LMNA (0.36) | CYP1A2MAPK1LMNAGMNNMAPT | |
| SCHEMBL15472454 | 0.78 | LMNA (0.47) | CYP1A2MAPK1LMNAMAPTTSHR | |
| SCHEMBL15472456 | 0.78 | LMNA (0.47) | CYP1A2MAPK1LMNAMAPTTSHR | |
| SCHEMBL4458105 | 0.78 | LMNA (0.33) | CYP1A2MAPK1LMNAGMNNMAPT | |
| SCHEMBL25099744 | 0.77 | LMNA (0.59) | CYP1A2MAPK1LMNAGMNNMAPT | |
| SCHEMBL13210313 | 0.77 | LMNA (0.59) | CYP1A2MAPK1LMNAGMNNMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2348833-A2 | LIQUID AQUEOUS CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2346322-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2011-07-27 | — | — | EP | disclosed |
| WO-2010040835-A2 | LIQUID PYRACLOSTROBIN-CONTAINING CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010040834-A2 | LIQUID AQUEOUS CROP PROTECTION FORMULATIONS | BASF SE (DE) | 2010-04-15 | — | — | WO | disclosed |
| US-20080039531-A1 | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders | STRACHER ALFRED | 2008-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080039531-A1 | Compositions, and kits comprising targeted aldehyde or acetal protease inhibitor compounds for treating muscle disorders | CPT1B, CAPNS1, CAPN1 | CYP1A2 4395/4885MAPK1 3779/4885LMNA 153/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.